Panagora Asset Management Inc Castle Biosciences Inc Transaction History

Panagora Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$60.13 - $77.6 $1,683 - $2,172	-28 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$50.07 - $76.78 $1,401 - $2,149	28 New	28 $2,000
Q1 2021 May 12, 2021	SELL	$58.92 - $97.33 $949,731 - $1.57 Million	-16,119 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$43.6 - $73.05 $16,044 - $26,882	368 Added 2.34%	16,119 $1.08 Million
Q3 2020 Nov 13, 2020	SELL	$38.47 - $52.03 $230 - $312	-6 Reduced 0.04%	15,751 $810,000
Q2 2020 Aug 12, 2020	BUY	$27.28 - $43.01 $65,253 - $102,879	2,392 Added 17.9%	15,757 $594,000
Q1 2020 May 14, 2020	BUY	$23.08 - $35.53 $303,871 - $467,787	13,166 Added 6616.08%	13,365 $398,000
Q4 2019 Feb 12, 2020	BUY	$15.74 - $35.04 $3,132 - $6,972	199 New	199 $7,000

202

26M

303K

30.3K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $739M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.